Intuitive Surgical, Inc. vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Consumer Discretionary Select Sector SPDR Fund trades at $112.85 (market cap $21.89B). The key difference: Intuitive Surgical, Inc. is far larger — about 6.7× Consumer Discretionary Select Sector SPDR Fund's market cap, and Consumer Discretionary Select Sector SPDR Fund is more actively traded (5,690,342 versus 2,529,814). Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Consumer Discretionary Select Sector SPDR Fund for 114 Days on average.
| ISRG | XLY | |
|---|---|---|
Market Cap | $146.76B | $21.89B |
Volume | 2,529,814 | 5,690,342 |
Sector | Health | — |
52-Week High | $592.85 | $124.52 |
52-Week Low | $332.02 | $105.64 |
Typical Hold Time | 84 Days | 114 Days |
Enterprise Value | $141.54B | — |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
XLY trades at $111.70 with a modest 0.31% daily gain, showing stability amid mixed technical signals. The ETF maintains a bullish overall technical rating despite underperforming consumer staples peers year-to-date. Analyst consensus remains unanimously positive with 100% buy ratings, though recent news highlights concerns about persistent underperformance versus the S&P 500 and inflationary pressures on consumer discretionary spending.
The outlook for XLY hinges on consumer resilience amid inflation, with potential catalysts from holiday sales growth and 'funflation' trends. Key risks include continued market underperformance and sensitivity to economic cycles. Institutional sentiment appears cautiously optimistic given the concentrated buy ratings, though technical indicators suggest near-term consolidation around current price levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.
Read more on XLY →